Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page
- CheckyesterdayChange DetectedA notice announces an NIH transition update, including a statement that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, indicating access to the record is blocked at this time.SummaryDifference18%

- Check58 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a minor version update that does not alter the displayed study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's software revision label was updated from v3.6.4 to v3.6.5. This indicates a newer release of the page's underlying system rather than any substantive update to the study information.SummaryDifference0.0%

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.